Cotton wool spots in patients with migraine
Mon statut pour la session
Access the Live Meeting: https://www.yourconference.live/COS
Authors: Po Hsiang (Shawn) Yuan, Jonathan Micieli.
Disclosure Block: P. Yuan: None. J. Micieli: None.
Abstract Body:
Purpose: To
report and discuss the association between cotton wool spot (CWS) findings and
migraines.
Study Design: Retrospective case review.
Methods: We retrospectively reviewed patients presenting to a
comprehensive ophthalmology and neuro-ophthalmology practice with CWS. Research
ethics board approval from the University of Toronto Research Ethics Board was
obtained.
Inclusion criteria included i) negative extensive systemic workup for known CWS
etiologies as outlined below ii) history of or subsequent development of
migraine with or without aura or typical aura without migraine. Exclusion
criteria included i) ocular findings consistent with a retinal vein occlusion,
diabetic retinopathy or hypertensive retinopathy ii) branch or central retinal
artery occlusion iii) known systemic disease associated with CWS.
For inclusion, the systemic workup must have included a blood pressure less
than 140/90, normal hemoglobin A1c (less than 6.0), and systemic evaluation
including normal or negative erythrocyte sedimentation rate, C-reactive
protein, antiphospholipid antibodies, antithrombin assay, factor V mutation,
fibrinogen, homocysteine, lupus anticoagulant, protein C and S assay,
prothrombin gene mutation, serum protein electrophoresis, antinuclear antibody,
anti-neurotrophil cytoplasmic antibody, rheumatoid factor, C3/4,HIV and
VDRL/RPR. Patients must also have had computed tomography or magnetic resonance
angiography of the head and neck to rule out carotid disease or signs of
vasculitis. Clinical and demographic information were retrieved for analysis.
Results: Four patients (2 male, 2 female) with a mean age of 33.8 years
(range 27 to 40) had no known medical conditions apart from migraine. The two
female patients were taking oral contraceptive pills. Three patients had a
history of migraine (ICHD-3 definition) and one patient developed new typical
visual auras without headache 1 month after the discovery of the CWS. Three
patients presented due to a new scotoma in the affected eye and one patient had
an incidentally discovered CWS during an eye exam for an unrelated reason. The
scotoma was described as sudden in all patients and took the form of a
“smudge”, “grain of rice”, and a “line”. Two patients had an associated
migraine headache at the time of the visual disturbance. In patients with
pre-existing migraine, the mean duration of migraine diagnosis was 15.3 years
and 2 patients had migraine with visual aura and 1 patient had migraine without
aura. Visual acuity and Humphrey visual fields were normal in all patients and
dilated fundus examination revealed an isolated CWS in 3 patients and a CWS
with an associated hemorrhage in one patient. The subjective scotoma fully
reversed in 2 patients and time to resolution ranged from 1 to 9 days. One
patient had an improved but persisting small scotoma that was not detectable on
formal visual field testing.
Conclusions: CWS may be discovered in the ophthalmic assessment of
patients with new visual disturbances or be an incidental finding. Our case
series suggests that CWS can be seen in the context of migraine and should be
considered in the differential diagnosis for this examination finding. However,
this diagnosis should only be made after exclusion of other known causes of CWS
including but not limited to hypertension and diabetes.